BioCentury | Jan 6, 2021
Management Tracks

Lin leaving Nektar as CMO; plus HKEX’s Tai named interim CEO, PureTech, Patient Square Capital, Novacyt and more

...board at Radius Health Inc. (NASDAQ:RDUS). Jessica Hopfield and Tony Rosenberg stepped down from the board. BC Staff Nektar PureTech Novacyt Checkmate Pharma Radius...
BioCentury | Sep 29, 2020
Management Tracks

Garijo picked to succeed Oschmann at Merck KGaA; plus BioShin, Abeona, Rubius, Nimbus, Vizgen

...strategic alternatives.Rubius Therapeutics Inc. (NASDAQ:RUBY) hired Jose “Pepe” Carmona as CFO. He held the same title at Radius...
BioCentury | Aug 7, 2020
Regulation

Guardant’s liquid biopsy approval paves the way for broader adoption of solid tumor profiling

...including the Janssen Pharmaceutical Cos. division of Johnson & Johnson (NYSE:JNJ), Amgen Inc. (NASDAQ:AMGN) and Radius...
BioCentury | May 14, 2020
Management Tracks

Jakob Dupont steps down as CMO of Gossamer; plus Ascendis, Seer, Jazz, Dragonfly and more

...NASDAQ:ASND) hired Jesper Høiland as global chief commercial officer. He was president and CEO of Radius...
BioCentury | Apr 30, 2020
Management Tracks

Desmond-Hellmann joins GV as adviser; plus Radius, Anika, AMAG, AiCure and more

...female chancellor of the University of California at San Francisco in 2009-14. Endocrine therapeutics company Radius...
...Sun as a venture partner. He was CTO of WuXi NextCode Genomics Inc. Robin Sawka, BioCentury Staff Radius...
BioCentury | Jan 25, 2020
Product Development

Radiotherapy blasts forward

...overcome resistance to beta-emitters linked to the same targeting ligand. However, the fact that the radius...
BioCentury | Dec 20, 2019
Product Development

Rise of the first-time biotech CEO

...“entrepreneurs in their mid-40s and mid-50s”, which could limit the pool. To broaden Atlas’ search radius...
BioCentury | Dec 10, 2019
Emerging Company Profile

Zentalis debuts with trio of clinical oncology programs, $85M series C

...SERDs are in the clinic for breast cancer, including Phase III candidate elacestrant (RAD1901) from Radius...
BioCentury | Oct 28, 2019
Finance

Nuvation Bio taking multimechanism approach with $275M series A

...Rounding out the C-suite are CSO Gary Hattersley, who was SVP and CSO at Radius...
BioCentury | May 29, 2019
Company News

Management tracks: Gilead replaces Hamill with BMS's Mercier; plus Alnylam, Audentes and more

...counsel and Karsten Witt as SVP of clinical development. Hatzis-Schoch was SVP, general counsel of Radius...
Items per page:
1 - 10 of 275
BioCentury | Jan 6, 2021
Management Tracks

Lin leaving Nektar as CMO; plus HKEX’s Tai named interim CEO, PureTech, Patient Square Capital, Novacyt and more

...board at Radius Health Inc. (NASDAQ:RDUS). Jessica Hopfield and Tony Rosenberg stepped down from the board. BC Staff Nektar PureTech Novacyt Checkmate Pharma Radius...
BioCentury | Sep 29, 2020
Management Tracks

Garijo picked to succeed Oschmann at Merck KGaA; plus BioShin, Abeona, Rubius, Nimbus, Vizgen

...strategic alternatives.Rubius Therapeutics Inc. (NASDAQ:RUBY) hired Jose “Pepe” Carmona as CFO. He held the same title at Radius...
BioCentury | Aug 7, 2020
Regulation

Guardant’s liquid biopsy approval paves the way for broader adoption of solid tumor profiling

...including the Janssen Pharmaceutical Cos. division of Johnson & Johnson (NYSE:JNJ), Amgen Inc. (NASDAQ:AMGN) and Radius...
BioCentury | May 14, 2020
Management Tracks

Jakob Dupont steps down as CMO of Gossamer; plus Ascendis, Seer, Jazz, Dragonfly and more

...NASDAQ:ASND) hired Jesper Høiland as global chief commercial officer. He was president and CEO of Radius...
BioCentury | Apr 30, 2020
Management Tracks

Desmond-Hellmann joins GV as adviser; plus Radius, Anika, AMAG, AiCure and more

...female chancellor of the University of California at San Francisco in 2009-14. Endocrine therapeutics company Radius...
...Sun as a venture partner. He was CTO of WuXi NextCode Genomics Inc. Robin Sawka, BioCentury Staff Radius...
BioCentury | Jan 25, 2020
Product Development

Radiotherapy blasts forward

...overcome resistance to beta-emitters linked to the same targeting ligand. However, the fact that the radius...
BioCentury | Dec 20, 2019
Product Development

Rise of the first-time biotech CEO

...“entrepreneurs in their mid-40s and mid-50s”, which could limit the pool. To broaden Atlas’ search radius...
BioCentury | Dec 10, 2019
Emerging Company Profile

Zentalis debuts with trio of clinical oncology programs, $85M series C

...SERDs are in the clinic for breast cancer, including Phase III candidate elacestrant (RAD1901) from Radius...
BioCentury | Oct 28, 2019
Finance

Nuvation Bio taking multimechanism approach with $275M series A

...Rounding out the C-suite are CSO Gary Hattersley, who was SVP and CSO at Radius...
BioCentury | May 29, 2019
Company News

Management tracks: Gilead replaces Hamill with BMS's Mercier; plus Alnylam, Audentes and more

...counsel and Karsten Witt as SVP of clinical development. Hatzis-Schoch was SVP, general counsel of Radius...
Items per page:
1 - 10 of 275